USA – FDA proposes update to 18-year guidance on developing weight loss drugs

The US Food and Drug Administration (FDA) has published draft guidance for sponsors developing drugs and biologics for weight reduction for patients who are...

USA – AI in drug development: FDA draft guidance addresses product lifecycle, risk

The US Food and Drug Administration (FDA) has released a new draft guidance on the use of artificial intelligence (AI) that produces data or...

USA – Batch uniformity: FDA details testing approaches for continuous manufacturing, 3D printing

The US Food and Drug Administration (FDA) has issued draft guidance to assist manufacturers in complying with its good manufacturing practice (GMP) regulations under...

Europe – A common EU approach to data transparency in medicine regulation

EMA and HMA (Heads of Medicines Agencies) have published a comprehensive overhaul of their guidance on the identification of commercially confidential information (CCI) and...

Europe – Successful pilot paves the way for implementation of ePI

The report of a pilot exploring the creation and testing of ePIs (electronic product information) in real regulatory procedures was published today. The pilot...

Europe – First medicine to treat rare genetic disorder causing cysts and tumours

EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Welireg (belzutifan) in adults with certain von Hippel-Lindau (VHL) disease-associated tumours and...

UK – NICE recommends Santhera’s Duchenne muscular dystrophy drug Agamree

The drug has been recommended for use on the NHS in England, Wales and Northern Ireland to treat the rare muscle-wasting disorder in those...

Europe – First treatment for peripheral thyrotoxicosis in patients with Allan-Herndon-Dudley syndrome

EMA has recommended granting a marketing authorisation in the European Union (EU) for Emcitate (tiratricol), an oral treatment for peripheral thyrotoxicosis (inappropriately high levels of circulating...

Europe – Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP)...

Seventeen new medicines recommended for approval EMA’s human medicines committee (CHMP) recommended seventeen medicines for approval at its December 2024 meeting. This brings the total...

Europe – First treatment recommended for rare progressive lung conditions in children and adolescents

EMA has recommended extending the indication of Ofev (nintedanib) to include the treatment of progressive fibrosing interstitial lung diseases (ILDs) in children and adolescents from the age of...

NOS PROCHAINES FORMATIONS